ID   HXK4_RAT                Reviewed;         465 AA.
AC   P17712; P17711;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 2.
DT   02-OCT-2024, entry version 184.
DE   RecName: Full=Hexokinase-4 {ECO:0000305};
DE            Short=HK4 {ECO:0000305};
DE            EC=2.7.1.1 {ECO:0000269|PubMed:12513690, ECO:0000269|PubMed:6477520};
DE   AltName: Full=Glucokinase {ECO:0000303|PubMed:2909525};
DE   AltName: Full=Hexokinase type IV {ECO:0000303|PubMed:6477520};
DE            Short=HK IV {ECO:0000303|PubMed:6477520};
DE   AltName: Full=Hexokinase-D {ECO:0000303|PubMed:6477520};
GN   Name=Gck {ECO:0000312|RGD:2670};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=2909525; DOI=10.1016/s0021-9258(17)31266-8;
RA   Andreone T.L., Printz R.L., Pilkis S.J., Magnuson M.A., Granner D.K.;
RT   "The amino acid sequence of rat liver glucokinase deduced from cloned
RT   cDNA.";
RL   J. Biol. Chem. 264:363-369(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Liver;
RX   PubMed=2396986; DOI=10.1042/bj2700261;
RA   Hayzer D.J., Iynedjian P.B.;
RT   "Alternative splicing of glucokinase mRNA in rat liver.";
RL   Biochem. J. 270:261-263(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 1-15 (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=2550428; DOI=10.1016/s0021-9258(18)71569-x;
RA   Magnuson M.A., Shelton K.D.;
RT   "An alternate promoter in the glucokinase gene is active in the pancreatic
RT   beta cell.";
RL   J. Biol. Chem. 264:15936-15942(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-15 (ISOFORM 3).
RX   PubMed=2662183; DOI=10.1073/pnas.86.13.4838;
RA   Magnuson M.A., Andeone T.L., Printz R.L., Koch S., Granner D.K.;
RT   "Rat glucokinase gene: structure and regulation by insulin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:4838-4842(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-15 (ISOFORM 3).
RX   PubMed=2590200; DOI=10.1016/0006-291x(89)91803-2;
RA   Noguchi T., Takenaka M., Yamada K., Matsuda T., Hashimoto M., Tanaka T.;
RT   "Characterization of the 5' flanking region of rat glucokinase gene.";
RL   Biochem. Biophys. Res. Commun. 164:1247-1252(1989).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-166 (ISOFORM 1).
RX   PubMed=1999433; DOI=10.1016/s0021-9258(20)64354-x;
RA   Hughes S.D., Quaade C., Milburn J.L., Cassidy L., Newgard C.B.;
RT   "Expression of normal and novel glucokinase mRNAs in anterior pituitary and
RT   islet cells.";
RL   J. Biol. Chem. 266:4521-4530(1991).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=6477520; DOI=10.1042/bj2220363;
RA   Cardenas M.L., Rabajille E., Niemeyer H.;
RT   "Fructose is a good substrate for rat liver 'glucokinase' (hexokinase D).";
RL   Biochem. J. 222:363-370(1984).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=3515342; DOI=10.1073/pnas.83.7.1998;
RA   Iynedjian P.B., Moebius G., Seitz H.J., Wollheim C.B., Renold A.E.;
RT   "Tissue-specific expression of glucokinase: identification of the gene
RT   product in liver and pancreatic islets.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:1998-2001(1986).
RN   [9]
RP   ACTIVITY REGULATION, INTERACTION WITH GCKR, AND SUBCELLULAR LOCATION.
RX   PubMed=10456334; DOI=10.1016/s0014-5793(99)00971-0;
RA   de la Iglesia N., Veiga-da-Cunha M., Van Schaftingen E., Guinovart J.J.,
RA   Ferrer J.C.;
RT   "Glucokinase regulatory protein is essential for the proper subcellular
RT   localisation of liver glucokinase.";
RL   FEBS Lett. 456:332-338(1999).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12513690; DOI=10.1042/bj20020728;
RA   Monasterio O., Cardenas M.L.;
RT   "Kinetic studies of rat liver hexokinase D ('glucokinase') in non-co-
RT   operative conditions show an ordered mechanism with MgADP as the last
RT   product to be released.";
RL   Biochem. J. 371:29-38(2003).
RN   [11]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH GCKR.
RX   PubMed=16542652; DOI=10.1016/j.febslet.2006.03.009;
RA   Arden C., Baltrusch S., Agius L.;
RT   "Glucokinase regulatory protein is associated with mitochondria in
RT   hepatocytes.";
RL   FEBS Lett. 580:2065-2070(2006).
RN   [12]
RP   INTERACTION WITH MIDN, AND FUNCTION.
RX   PubMed=24187134; DOI=10.1074/jbc.m113.526632;
RA   Hofmeister-Brix A., Kollmann K., Langer S., Schultz J., Lenzen S.,
RA   Baltrusch S.;
RT   "Identification of the ubiquitin-like domain of midnolin as a new
RT   glucokinase interaction partner.";
RL   J. Biol. Chem. 288:35824-35839(2013).
CC   -!- FUNCTION: Catalyzes the phosphorylation of hexose, such as D-glucose,
CC       D-fructose and D-mannose, to hexose 6-phosphate (D-glucose 6-phosphate,
CC       D-fructose 6-phosphate and D-mannose 6-phosphate, respectively)
CC       (PubMed:12513690, PubMed:24187134, PubMed:6477520). Compared to other
CC       hexokinases, has a weak affinity for D-glucose, and is effective only
CC       when glucose is abundant (PubMed:6477520). Mainly expressed in
CC       pancreatic beta cells and the liver and constitutes a rate-limiting
CC       step in glucose metabolism in these tissues (By similarity). Since
CC       insulin secretion parallels glucose metabolism and the low glucose
CC       affinity of GCK ensures that it can change its enzymatic activity
CC       within the physiological range of glucose concentrations, GCK acts as a
CC       glucose sensor in the pancreatic beta cell (By similarity). In
CC       pancreas, plays an important role in modulating insulin secretion (By
CC       similarity). In liver, helps to facilitate the uptake and conversion of
CC       glucose by acting as an insulin-sensitive determinant of hepatic
CC       glucose usage (By similarity). Required to provide D-glucose 6-
CC       phosphate for the synthesis of glycogen (By similarity). Mediates the
CC       initial step of glycolysis by catalyzing phosphorylation of D-glucose
CC       to D-glucose 6-phosphate (PubMed:12513690, PubMed:6477520).
CC       {ECO:0000250|UniProtKB:P52792, ECO:0000269|PubMed:12513690,
CC       ECO:0000269|PubMed:24187134, ECO:0000269|PubMed:6477520}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a D-hexose + ATP = a D-hexose 6-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:22740, ChEBI:CHEBI:4194, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:229467, ChEBI:CHEBI:456216;
CC         EC=2.7.1.1; Evidence={ECO:0000269|PubMed:12513690,
CC         ECO:0000269|PubMed:6477520};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22741;
CC         Evidence={ECO:0000269|PubMed:12513690, ECO:0000269|PubMed:6477520};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + D-fructose = ADP + D-fructose 6-phosphate + H(+);
CC         Xref=Rhea:RHEA:16125, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:37721, ChEBI:CHEBI:61527, ChEBI:CHEBI:456216; EC=2.7.1.1;
CC         Evidence={ECO:0000269|PubMed:6477520};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16126;
CC         Evidence={ECO:0000269|PubMed:6477520};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + D-glucose = ADP + D-glucose 6-phosphate + H(+);
CC         Xref=Rhea:RHEA:17825, ChEBI:CHEBI:4167, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61548, ChEBI:CHEBI:456216; EC=2.7.1.1;
CC         Evidence={ECO:0000269|PubMed:12513690, ECO:0000269|PubMed:6477520};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17826;
CC         Evidence={ECO:0000269|PubMed:12513690, ECO:0000269|PubMed:6477520};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + D-mannose = ADP + D-mannose 6-phosphate + H(+);
CC         Xref=Rhea:RHEA:11028, ChEBI:CHEBI:4208, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:58735, ChEBI:CHEBI:456216; EC=2.7.1.1;
CC         Evidence={ECO:0000250|UniProtKB:P35557};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11029;
CC         Evidence={ECO:0000250|UniProtKB:P35557};
CC   -!- ACTIVITY REGULATION: Subject to allosteric regulation (By similarity).
CC       Low glucose and high fructose-6-phosphate triggers association with the
CC       inhibitor GCKR followed by sequestration in the nucleus
CC       (PubMed:10456334). {ECO:0000250|UniProtKB:P35557,
CC       ECO:0000269|PubMed:10456334}.
CC   -!- PATHWAY: Carbohydrate metabolism; hexose metabolism.
CC       {ECO:0000305|PubMed:12513690, ECO:0000305|PubMed:6477520}.
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-
CC       phosphate and glycerone phosphate from D-glucose: step 1/4.
CC       {ECO:0000305|PubMed:12513690, ECO:0000305|PubMed:6477520}.
CC   -!- SUBUNIT: Monomer (By similarity). Interacts with MIDN; the interaction
CC       occurs preferentially at low glucose levels and results in inhibition
CC       of hexokinase activity (PubMed:24187134). Interacts with GCKR; leading
CC       to sequestration in the nucleus (PubMed:10456334, PubMed:16542652).
CC       {ECO:0000250|UniProtKB:P35557, ECO:0000269|PubMed:10456334,
CC       ECO:0000269|PubMed:16542652, ECO:0000269|PubMed:24187134}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10456334,
CC       ECO:0000269|PubMed:16542652}. Nucleus {ECO:0000269|PubMed:10456334}.
CC       Mitochondrion {ECO:0000269|PubMed:16542652}. Note=Under low glucose
CC       concentrations, associates with GCKR and the inactive complex is
CC       recruited to the hepatocyte nucleus. {ECO:0000269|PubMed:10456334}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=3;
CC         Comment=A number of isoforms are produced by alternative promoter
CC         usage. The use of alternative promoters apparently enables the type
CC         IV hexokinase gene to be regulated by insulin in the liver and
CC         glucose in the beta cell. This may constitute an important feedback
CC         loop for maintaining glucose homeostasis.
CC         {ECO:0000250|UniProtKB:P35557};
CC       Name=1;
CC         IsoId=P17712-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P17712-2; Sequence=VSP_002078;
CC       Name=3;
CC         IsoId=P17712-3; Sequence=VSP_002077;
CC   -!- TISSUE SPECIFICITY: Expression is restricted to the liver and
CC       pancreatic islets (at protein level). {ECO:0000269|PubMed:3515342}.
CC   -!- SIMILARITY: Belongs to the hexokinase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01084, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J04218; AAA41229.1; -; mRNA.
DR   EMBL; M24952; AAA41230.1; -; Genomic_DNA.
DR   EMBL; M24943; AAA41230.1; JOINED; Genomic_DNA.
DR   EMBL; M24944; AAA41230.1; JOINED; Genomic_DNA.
DR   EMBL; M24945; AAA41230.1; JOINED; Genomic_DNA.
DR   EMBL; M24947; AAA41230.1; JOINED; Genomic_DNA.
DR   EMBL; M24948; AAA41230.1; JOINED; Genomic_DNA.
DR   EMBL; M24949; AAA41230.1; JOINED; Genomic_DNA.
DR   EMBL; M24950; AAA41230.1; JOINED; Genomic_DNA.
DR   EMBL; M24951; AAA41230.1; JOINED; Genomic_DNA.
DR   EMBL; M25806; AAA41238.1; -; Genomic_DNA.
DR   EMBL; M25807; AAA41239.1; -; mRNA.
DR   EMBL; M58759; AAA41236.1; -; mRNA.
DR   EMBL; X53588; CAA37657.1; -; mRNA.
DR   EMBL; X53590; CAA37660.1; -; Genomic_DNA.
DR   EMBL; M30770; AAA41231.1; -; Genomic_DNA.
DR   PIR; A31810; A31810.
DR   PIR; I84740; I84740.
DR   RefSeq; NP_001257779.1; NM_001270850.1. [P17712-2]
DR   RefSeq; NP_036697.1; NM_012565.2. [P17712-3]
DR   RefSeq; XP_006251241.1; XM_006251179.3. [P17712-1]
DR   AlphaFoldDB; P17712; -.
DR   SMR; P17712; -.
DR   IntAct; P17712; 2.
DR   MINT; P17712; -.
DR   STRING; 10116.ENSRNOP00000068656; -.
DR   BindingDB; P17712; -.
DR   ChEMBL; CHEMBL3882; -.
DR   PhosphoSitePlus; P17712; -.
DR   PaxDb; 10116-ENSRNOP00000019625; -.
DR   Ensembl; ENSRNOT00000086343.2; ENSRNOP00000071435.1; ENSRNOG00000061527.2. [P17712-3]
DR   Ensembl; ENSRNOT00000086474.2; ENSRNOP00000069954.2; ENSRNOG00000061527.2. [P17712-1]
DR   Ensembl; ENSRNOT00055052150; ENSRNOP00055043085; ENSRNOG00055030038. [P17712-1]
DR   Ensembl; ENSRNOT00060055274; ENSRNOP00060045718; ENSRNOG00060031866. [P17712-1]
DR   Ensembl; ENSRNOT00065034467; ENSRNOP00065027614; ENSRNOG00065020364. [P17712-1]
DR   GeneID; 24385; -.
DR   KEGG; rno:24385; -.
DR   UCSC; RGD:2670; rat. [P17712-1]
DR   AGR; RGD:2670; -.
DR   CTD; 2645; -.
DR   RGD; 2670; Gck.
DR   eggNOG; KOG1369; Eukaryota.
DR   GeneTree; ENSGT00950000182787; -.
DR   InParanoid; P17712; -.
DR   OrthoDB; 5481886at2759; -.
DR   PhylomeDB; P17712; -.
DR   BRENDA; 2.7.1.1; 5301.
DR   Reactome; R-RNO-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-RNO-70171; Glycolysis.
DR   SABIO-RK; P17712; -.
DR   UniPathway; UPA00109; UER00180.
DR   UniPathway; UPA00242; -.
DR   PRO; PR:P17712; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000061527; Expressed in liver and 4 other cell types or tissues.
DR   ExpressionAtlas; P17712; baseline and differential.
DR   GO; GO:0005884; C:actin filament; IDA:RGD.
DR   GO; GO:0045180; C:basal cortex; IDA:RGD.
DR   GO; GO:0005938; C:cell cortex; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0043531; F:ADP binding; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0005536; F:D-glucose binding; IDA:RGD.
DR   GO; GO:0008865; F:fructokinase activity; IDA:UniProtKB.
DR   GO; GO:0004340; F:glucokinase activity; IDA:UniProtKB.
DR   GO; GO:0141089; F:glucose sensor activity; IDA:BHF-UCL.
DR   GO; GO:0004396; F:hexokinase activity; ISO:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:RGD.
DR   GO; GO:0019158; F:mannokinase activity; IDA:UniProtKB.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:RGD.
DR   GO; GO:0070509; P:calcium ion import; ISO:RGD.
DR   GO; GO:0046835; P:carbohydrate phosphorylation; IDA:RGD.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IMP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IDA:BHF-UCL.
DR   GO; GO:0044320; P:cellular response to leptin stimulus; IDA:BHF-UCL.
DR   GO; GO:0006003; P:fructose 2,6-bisphosphate metabolic process; IDA:RGD.
DR   GO; GO:0006002; P:fructose 6-phosphate metabolic process; IDA:UniProtKB.
DR   GO; GO:0051156; P:glucose 6-phosphate metabolic process; IDA:UniProtKB.
DR   GO; GO:0006007; P:glucose catabolic process; ISS:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; IDA:RGD.
DR   GO; GO:0005978; P:glycogen biosynthetic process; IDA:RGD.
DR   GO; GO:0006096; P:glycolytic process; IDA:RGD.
DR   GO; GO:0001678; P:intracellular glucose homeostasis; IMP:RGD.
DR   GO; GO:0055088; P:lipid homeostasis; IDA:RGD.
DR   GO; GO:0006013; P:mannose metabolic process; IDA:UniProtKB.
DR   GO; GO:0006739; P:NADP metabolic process; ISO:RGD.
DR   GO; GO:0032811; P:negative regulation of epinephrine secretion; IMP:RGD.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD.
DR   GO; GO:0045725; P:positive regulation of glycogen biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0045821; P:positive regulation of glycolytic process; IDA:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IDA:RGD.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IDA:RGD.
DR   GO; GO:1902659; P:regulation of glucose mediated signaling pathway; IMP:RGD.
DR   GO; GO:0050796; P:regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0043266; P:regulation of potassium ion transport; ISO:RGD.
DR   GO; GO:0009749; P:response to glucose; IDA:BHF-UCL.
DR   CDD; cd00012; NBD_sugar-kinase_HSP70_actin; 1.
DR   Gene3D; 3.30.420.40; -; 1.
DR   Gene3D; 3.40.367.20; -; 1.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR001312; Hexokinase.
DR   InterPro; IPR019807; Hexokinase_BS.
DR   InterPro; IPR022673; Hexokinase_C.
DR   InterPro; IPR022672; Hexokinase_N.
DR   PANTHER; PTHR19443; HEXOKINASE; 1.
DR   PANTHER; PTHR19443:SF3; HEXOKINASE-4; 1.
DR   Pfam; PF00349; Hexokinase_1; 1.
DR   Pfam; PF03727; Hexokinase_2; 1.
DR   PRINTS; PR00475; HEXOKINASE.
DR   SUPFAM; SSF53067; Actin-like ATPase domain; 2.
DR   PROSITE; PS00378; HEXOKINASE_1; 1.
DR   PROSITE; PS51748; HEXOKINASE_2; 1.
PE   1: Evidence at protein level;
KW   Allosteric enzyme; Alternative promoter usage; Alternative splicing;
KW   ATP-binding; Cytoplasm; Direct protein sequencing; Glycolysis; Kinase;
KW   Mitochondrion; Nucleotide-binding; Nucleus; Reference proteome;
KW   Transferase.
FT   CHAIN           1..465
FT                   /note="Hexokinase-4"
FT                   /id="PRO_0000197595"
FT   DOMAIN          10..454
FT                   /note="Hexokinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01084"
FT   REGION          67..203
FT                   /note="Hexokinase small subdomain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01084"
FT   REGION          204..443
FT                   /note="Hexokinase large subdomain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01084"
FT   BINDING         78..83
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P19367"
FT   BINDING         151..152
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P35557"
FT   BINDING         168..169
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P35557"
FT   BINDING         204..205
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P35557"
FT   BINDING         228
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P35557"
FT   BINDING         231
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P35557"
FT   BINDING         256
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P35557"
FT   BINDING         290
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P35557"
FT   BINDING         295..296
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P35557"
FT   BINDING         332..336
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P35557"
FT   BINDING         411..415
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P35557"
FT   VAR_SEQ         1..15
FT                   /note="MLDDRARMEATKKEK -> MAMDTTRCGAQLLTL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:2909525"
FT                   /id="VSP_002077"
FT   VAR_SEQ         122..138
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_002078"
SQ   SEQUENCE   465 AA;  52116 MW;  65B36673DF9297BE CRC64;
     MLDDRARMEA TKKEKVEQIL AEFQLQEEDL KKVMSRMQKE MDRGLRLETH EEASVKMLPT
     YVRSTPEGSE VGDFLSLDLG GTNFRVMLVK VGEGEAGQWS VKTKHQMYSI PEDAMTGTAE
     MLFDYISECI SDFLDKHQMK HKKLPLGFTF SFPVRHEDLD KGILLNWTKG FKASGAEGNN
     IVGLLRDAIK RRGDFEMDVV AMVNDTVATM ISCYYEDRQC EVGMIVGTGC NACYMEEMQN
     VELVEGDEGR MCVNTEWGAF GDSGELDEFL LEYDRMVDES SANPGQQLYE KIIGGKYMGE
     LVRLVLLKLV DENLLFHGEA SEQLRTRGAF ETRFVSQVES DSGDRKQIHN ILSTLGLRPS
     VTDCDIVRRA CESVSTRAAH MCSAGLAGVI NRMRESRSED VMRITVGVDG SVYKLHPSFK
     ERFHASVRRL TPNCEITFIE SEEGSGRGAA LVSAVACKKA CMLAQ
//
